Home - Products - Others - Other Targets - 4-Chloro-3-(trifluoromethyl)phenyl isocyanate

4-Chloro-3-(trifluoromethyl)phenyl isocyanate

CAS No. 327-78-6

4-Chloro-3-(trifluoromethyl)phenyl isocyanate( —— )

Catalog No. M37066 CAS No. 327-78-6

4-Chloro-3-(trifluoromethyl)phenyl isocyanate is a biochemical reagent that can be produced by a series of reactions between o-chlorobenzotrifluoride and acetic anhydride.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 27 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Chloro-3-(trifluoromethyl)phenyl isocyanate
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Chloro-3-(trifluoromethyl)phenyl isocyanate is a biochemical reagent that can be produced by a series of reactions between o-chlorobenzotrifluoride and acetic anhydride.
  • Description
    4-Chloro-3-(trifluoromethyl)phenyl isocyanate is a biochemical reagent that can be produced by a series of reactions between o-chlorobenzotrifluoride and acetic anhydride.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    327-78-6
  • Formula Weight
    221.56
  • Molecular Formula
    C8H3ClF3NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    FC(F)(F)c1cc(ccc1Cl)N=C=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Acetyl-(Nle4,Gln5,D-...

    Acetyl-(Nle4,Gln5,D-Phe7,D-Trp9)-α-MSH (4-10) amide

  • Aspartyl-alanyl-dike...

    Ampion is a known immunomodulatory molecule from the N terminus of human albumin.

  • Ibrolipim

    Ibrolipim attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway.